Facebook Linkedin RSS Twitter Youtube
Home 2024

Vertex Pharmaceuticals

Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration
Drug Discovery

Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration

A Story of Perseverance: An Interview with Matthew Porteus
GEN Edge

A Story of Perseverance: An Interview with Matthew Porteus

CRISPR 2.0: Kinder, Gentler, More Powerful Gene Editing
Genome Editing

CRISPR 2.0: Kinder, Gentler, More Powerful Gene Editing

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline
Drug Discovery

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline

CRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Tools
GEN Edge

CRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Tools

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles
Drug Discovery

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
GEN Edge

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough

Sickle Cell Salvation: The Victoria Gray Interview
Genome Editing

Sickle Cell Salvation: The Victoria Gray Interview

Improving Flow through the Cell Therapies Bottleneck
Bioprocessing

Improving Flow through the Cell Therapies Bottleneck

Solvias to Perform Release Testing on CASGEVY
Bioprocessing

Solvias to Perform Release Testing on CASGEVY

123...5Page 1 of 5
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.